MedTrace Logo

Physical Activity and Cerebral Metabolism in the Elderly: a Randomised Controlled Trial

NCT02343029 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2015-09-02

No results posted yet for this study

Summary

Physical activity exerts a variety of long-term health benefits in older adults.This randomised controlled trial investigates the effect of a 12-week physical exercise program on the change in cerebral metabolism as assessed with Magnetic Resonance Spectroscopic Imaging. Follow-up lasts for 6 months.

Conditions

Interventions

OTHER

Individualised aerobic exercise training

During the first 4 weeks of intervention two of the three weekly training sessions are offered as group training supervised by the respective qualified exercise physiologist of the Department of Sports Medicine. After 4 weeks, participants' physical performance is reassessed at the Department of Sports Medicine. If necessary, workload is readjusted to achieve the initially defined exercise intensity.

OTHER

Waiting Control

After waiting for 12 weeks with normal daily activity, patients are allocated to a individualised aerobic exercise training, too.

Sponsors & Collaborators

  • Professor Johannes Pantel

    lead OTHER

Principal Investigators

  • Johannes Pantel, Prof. · Institute of General Practice, Goethe University, Frankfurt/Main, Germany

  • Winfried E Banzer, Prof. · Department of Sports Medicine, Institute of Sports Sciences, Goethe University, Frankfurt/Main, Germany

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2015-08-31
Completion
2015-08-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02343029 on ClinicalTrials.gov